Related Experiment Video
Updated: Sep 14, 2025

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
Bioprocessed black rice bran protects mice against alcohol-induced fatty liver formation
Ki Sun Kwon1, Su A In1, Wha Young Lee1
1STR Biotech. Co. Ltd., Chuncheon 24232, Republic of Korea. spkim@strbiotech.co.kr.
Abstract:
Following consumption, alcohol is absorbed from the digestive tract into the circulation and is then distributed into different organs. In the liver, it causes a range of injuries beginning with the induction of fatty liver (hepatic steatosis), which on further alcohol consumption progresses to liver cirrhosis that can result in mortality. On the basis of a series of our previous published studies that showed that black rice-based functional foods have multi-functional health benefits in rodents, including protection of mice and rats against inflammation and alcohol-induced hangovers, we were motivated to determine the protective effect of a polysaccharide-containing bioprocessed (fermented) black rice bran product (BRB-F) to prevent alcohol-induced liver damage. BRB-F prevented dietary alcohol-induced increases in both whole liver and in liver fat weights, serum levels of hepatic enzymes and bilirubin, oxidized liver glutathione, and proinflammatory serum and adipocyte cytokines. Silymarin, a plant phenolic anti-inflammatory agent, cooperated with BRB-F to increase the prevention of alcohol-induced liver damage. BRB-F and silymarin also prevented direct toxicity of HepG2 human liver cells in culture by reducing reactive oxygen species. Mechanistic aspects and suggestions for further research are discussed. The ability of BRB-F alone or with silymarin to protect mice against alcohol-induced liver damage merits confirmation in human clinical studies.
More Related Videos
11:03Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
Published on: September 9, 2021
08:20Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022